🔍
Search Results - helen+dooley
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Multispecific Antibodies that Induce Downregulation of Programmed Death-ligand 1
Unmet Need: It is estimated that in 2018 there were more than 17 million new cases of cancer worldwide (see ACS). Immune checkpoint therapies have become a powerful treatment route for a wide variety of cancer types and have increased the life expectancy for patients whose disease is refractory to all other therapies. Due to variability in patient response...
Published: 3/14/2025
|
Inventor(s):
Jamie Spangler
,
Seth Ludwig
,
Angela Zhu
,
Rakeeb Kureshi
,
Helen Dooley
Keywords(s):
Category(s):
Technology Classifications > Therapeutic Modalities
,
Technology Classifications > Therapeutic Modalities > Antibodies
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum